Find your path to Elizabeth
211 people in our graph share verified history with Elizabeth — schools, employers, funds. One of them is your warm intro.
Ann Miura-KounlockedElizabeth: together at Yale University (1994–1995)
Elizabeth: together at UCSF
Elizabeth: together at The George Washington University
×4Elizabeth: together at Genentech
About
Elizabeth Jeffords is CEO and President of Iolyx Therapeutics, a venture-backed therapeutics company. Her prior experience includes P&L leadership roles at Roche, where she headed the Global Established Products Business Unit and served as CEO/GM of Roche Norway, and at Genentech, where she led the US Ophthalmology business as well as pricing, contracting, and strategic planning teams. She has overseen more than 14 product launches across areas including oncology, neurology, immunology, ophthalmology, and rare disease, and serves as a director at BIO.
CEO & President at Iolyx
Intro paths
→
In turn, Elizabeth can intro founders to Iolyx's investors below.
Iolyx's investors · 1
Experience
- Iolyx TherapeuticsCEO & Presidentcurrent2021 — presentSan Francisco Bay Area
- Ashvattha Therapeutics, Inc.Directorcurrent2025 — present
- Biotech CEO SisterhoodMembercurrent2022 — present
- Biotechnology Innovation OrganizationDirector, ECS and Health Sections, WDEI Committee Chaircurrent2022 — present
- Akorn, IncDirector, Board of Directors2020 — 2023
- Alkahest, Inc.Chief Commercial & Strategy Officer (Oct '18-Oct '20) & Consultant (May-Oct'18, and Nov'20-Mar'21)2018 — 2021San Francisco Bay Area
- GenentechVice President Ophthalmology Franchise Head2017 — 2018South San Francisco, Ca
- RocheCEO/General Manager/BOD, Roche Norway2015 — 2017Oslo, Oslo, Norway
- RocheVP, Global Business Unit Head Established Products, Global Head Commercial Operations2013 — 2015Basel, Basel, Switzerland
- GenentechSenior Director, US Strategic Pricing & Contract Management2010 — 2013
- GenentechSenior Director and various roles, Market Analysis & Strategy2001 — 2011South San Francisco, CA
- AvantGoBusiness Development/Marketing- Healthcare Vertical2000 — 2001Hayward/San Mateo, CA
- BioMedical Insights, Inc.Consultant1999 — 2000San Francisco, CA
- R B Webber ConsultingEngagement Manager1997 — 1999Palo Alto, CA
- UCSFResearch Associate1995 — 1996
- Yale UniversityResearch Associate1994 — 1995
Skills & more
Biotechnology19Cross-functional Team Leadership27Oncology24Competitive Analysis5Strategic Planning18Market Analysis12Management20Infectious Diseases2Pharmaceutical Industry9Lifesciences4Managed Care7Clinical Trials2
+8 more
StrategyBusiness DevelopmentPharmaceutical SalesCompetitive IntelligenceMedical DevicesLeadershipMarketing StrategyConsultingFrom Elizabeth's professional profile.
Frequently asked questions
- Who is Elizabeth Jeffords?
- Elizabeth Jeffords is CEO and President of Iolyx Therapeutics, a venture-backed therapeutics company. Her prior experience includes P&L leadership roles at Roche, where she headed the Global Established Products Business Unit and served as CEO/GM of Roche Norway, and at Genentech, where she led the US Ophthalmology business as well as pricing, contracting, and strategic planning teams. She has overseen more than 14 product launches across areas including oncology, neurology, immunology, ophthalmology, and rare disease, and serves as a director at BIO.
- Where does Elizabeth Jeffords work?
- Elizabeth Jeffords is CEO & President at Iolyx.
- Where did Elizabeth Jeffords go to school?
- Elizabeth Jeffords studied at Yale University (Bachelor's Degree, BS); UNSW (Master's Degree, Masters of Business & Technology); The George Washington University (Women In Bio's: Boardroom Ready Executive Development Program).
Same school
Also attended Yale University1,072
Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorBen SilbermannCo-founder of PinterestZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)
+ 1,066 more
Also attended UNSW464
Mike Cannon-BrookesCo-founder & CEO of AtlassianScott FarquharCo-founder of AtlassianJeremy PhilipsInvestor at Spark CapitalSimon CantInvestor at Reinventure GroupDanny GilliganInvestor at Reinventure GroupLeah MitchellChief of Staff at Differential Ventures
+ 458 more
Also attended The George Washington University382
RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauZach CollinsPartner at Mission Biocapital
+ 376 more
Shared employers
Also worked at Biotech CEO Sisterhood15
Shahid NimjeeCo-founder, Chief Scientific Officer and Stroke Clinical Lead at Basking BiosciencesYael WeissExecutive Officer, Director at Mahzi TherapeuticsJo VarshneyFounder at VeriSIM LifeSheila Gujrathi, MDFounder at Gossamer BioSandra DunnFounder at Phoenix Molecular DesignsCaitlyn KrebsCo-founder + CEO at NaluBio, Inc.
+ 9 more
Also worked at Biotechnology Innovation Organization33
Nessan BerminghamInvestor at Khosla VenturesTara SullivanPrincipal at Flare Capital PartnersJessica SagersCommunications Inquiries Contact at Deerfield Management CompanyJohn MaraganoreAdvisor at Oak HC/FTJohn GlasspoolVenture Partner at Agent CapitalThomas NagyOperational Partner at Astanor Ventures
+ 27 more
Also worked at Genentech245
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 239 more
